Sign In
Buy MCEM
$279.85
-4.15 (-1.46%)
At Close: Jun 22, 2026
Monarch Cement Q1 Earnings Jump Y/Y on Strong Cement Demand Trends
10:40am, Wednesday, 20'th May 2026
MCEM's Q1 earnings surge y/y on higher cement and concrete volumes, while margins expand amid stronger construction demand.
The Monarch Cement Company: The Easy Money Has Been Made, But More Upside Exists
07:00am, Monday, 30'th Mar 2026
The Monarch Cement Company remains a "buy" due to its strong balance sheet and attractive valuation, despite recent price appreciation. MCEM outperformed the S&P 500, rising 76.3% since December 2023,
Monarch Cement 2025 Earnings Fall Y/Y on Weak Concrete Demand
11:01am, Thursday, 19'th Mar 2026
MCEM's 2025 results show declining revenues and earnings as weak ready-mix demand offsets pricing gains and cost controls.
Monarch Cement (OTCMKTS:MCEM) Shares Cross Above Fifty Day Moving Average – What’s Next?
04:18am, Wednesday, 11'th Feb 2026
The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report)'s stock price passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $234.55 and trade
The Monarch Cement Co. (OTCMKTS:MCEM) Sees Significant Growth in Short Interest
03:22am, Tuesday, 03'rd Feb 2026
The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totaling 232 shares, a growth of
Monarch Cement (OTCMKTS:MCEM) Trading 3.6% Higher – Time to Buy?
02:55am, Sunday, 28'th Dec 2025
Shares of The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) were up 3.6% on Friday. The stock traded as high as $235.00 and last traded at $232.01. Approximately 699 shares traded hands during m
Monarch Cement (OTCMKTS:MCEM) Stock Price Passes Below 200 Day Moving Average – What’s Next?
03:58am, Saturday, 06'th Dec 2025
Shares of The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $232.24 and traded as low
The Monarch Cement Company: Underperformance Does Not Invalidate Upside
12:31pm, Thursday, 04'th Dec 2025
The Monarch Cement Company remains a 'Buy' despite recent share weakness and challenging market conditions, supported by a strong balance sheet and undervaluation. MCEM's Q3 2025 saw revenue and profi
Monarch Cement's Q3 Earnings Decline as Ready-Mix Sales Weaken
10:47am, Monday, 17'th Nov 2025
MCEM posts lower Q3 revenues and profit as ready-mix volumes drop, margins tighten, and market conditions soften amid weather and portfolio shifts.
The Monarch Cement Company: This Dip Offers A Buying Opportunity
10:22am, Thursday, 28'th Aug 2025
Despite recent underperformance, Monarch Cement remains a "Buy" due to its strong long-term outperformance versus the S&P 500 and solid balance sheet. Recent revenue and cash flow declines are disappo
Monarch Cement Q2 Earnings Rise Y/Y Despite Revenues & Margin Pressures
12:56pm, Wednesday, 20'th Aug 2025
MCEM's Q2 earnings rise y/y on higher profits from investments, but revenues fall on weaker concrete sales and margin pressure.
Monarch Cement Q1 Earnings Fall Y/Y on Weather, Investment Losses
02:46pm, Friday, 16'th May 2025
MCEM posts sharp Q1 earnings drop as bad weather hits sales and investment losses weigh on earnings despite solid margins and strong liquidity.
The Monarch Cement Company: This Undervalued Name Deserves Concrete Upside
02:27am, Tuesday, 13'th May 2025
Despite recent financial weakness, The Monarch Cement Company remains a 'buy' due to its attractive valuation and strong balance sheet with no debt and significant cash reserves. The company's revenue
Monarch Cement's Sales Increase Y/Y in 2024, Earnings Decline
10:55am, Wednesday, 19'th Mar 2025
MCEM sales rise 2% y/y in 2024, but net income falls 10.4% as cost pressures and lower volumes impact profitability.
The Monarch Cement Company: Despite A Downgrade, The Firm Still Justifies Upside
02:09am, Sunday, 16'th Feb 2025
The Monarch Cement Company has shown strong performance, with shares up 15.8% since August 2024 and 50.7% since December 2023, outperforming the S&P 500. Despite significant growth, the stock remains
